Search Results for 'drug hiv'

drug hiv published presentations and documents on DocSlides.

Special Issues Guidelines for the Use of
Special Issues Guidelines for the Use of
by olivia-moreira
Antiretroviral. Agents . in Adults and Adolescent...
Long Acting ART for Treatment and
Long Acting ART for Treatment and
by tatyana-admore
PrEP. Anton Pozniak . MD FRCP. Consultant Physici...
May 3, 2016: Hepatitis  C Kills More Americans than Any Other Infectious
May 3, 2016: Hepatitis C Kills More Americans than Any Other Infectious
by luanne-stotts
Disease. Annual Hepatitis . C-related mortality i...
The Role of Pre-Exposure Prophylaxis (
The Role of Pre-Exposure Prophylaxis (
by tatyana-admore
PrEP. ) for the Prevention of HIV. Sarah . Kemink...
AIDS CARE GROUP Grace Paik, CRNP
AIDS CARE GROUP Grace Paik, CRNP
by marina-yarberry
Regina . Ubaldi. -Rosen, CRNP. ELLAH NOTA, CRNP. ...
Comprehensive  Guideline Summary
Comprehensive Guideline Summary
by aaron
Guidelines for the Use of Antiretroviral Agents. ...
ART Initiation:  PrEP  and
ART Initiation: PrEP and
by alida-meadow
Treatment-naïve Patients . Clinical Instructor, ...
Generic treatments for HIV, HBV, HCV, TB could be mass produced for <$90 per patient
Generic treatments for HIV, HBV, HCV, TB could be mass produced for <$90 per patient
by min-jolicoeur
Dr Dzintars Gotham MBBS BSc(Hons). on behalf of. ...
July 2017 Lesson 1: Risk
July 2017 Lesson 1: Risk
by yoshiko-marsland
Behavior . Harm Reduction. Core Competency 2: . P...
W orking  with  Different Groups
W orking with Different Groups
by briana-ranney
Module 3 (f). People who Inject Drugs. People who...
Medication Assisted Therapy as a
Medication Assisted Therapy as a
by faustina-dinatale
M. eans to . Reduce Relapse to Opioid Use . and I...
Clinical  Management Module
Clinical Management Module
by stefany-barnette
4. . (b) . Risks and Side Effects. Overview. Res...
ART for Prevention… What Happens Next?
ART for Prevention… What Happens Next?
by briana-ranney
Myron S. Cohen, MD. Yeargan-Bate Eminent Professo...
Roy M. Gulick, MD, MPH Rochelle Belfer Professor in Medicine
Roy M. Gulick, MD, MPH Rochelle Belfer Professor in Medicine
by debby-jeon
Weill Cornell Medicine. New York, New York. Inves...
Comparison of Adherence among Partners’ PrEP Participants on Placebo before and after Release of
Comparison of Adherence among Partners’ PrEP Participants on Placebo before and after Release of
by briana-ranney
B. Wamuti. , J. Odoyo, B. Rono, C. Cohen, E. Buku...
Strategies to increase women’s participation in available
Strategies to increase women’s participation in available
by celsa-spraggs
Sophia Zamudio-Haas, DrPH MSc. Presented by Olivi...
ICASA Track
ICASA Track
by tatiana-dople
A – Basic Science. Rapporteur’s Report. GROUP...
Raltegravir for
Raltegravir for
by min-jolicoeur
t. he . p. revention . o. f . mother. -to-child ....
Switch
Switch
by lindy-dunigan
from. TDF to TAF. GS-US-292-0109 Study. GS-US-31...
Biochemical Examples of CHEM321/322 Concepts
Biochemical Examples of CHEM321/322 Concepts
by marina-yarberry
Stereochemistry. Many biomolecules, including pro...
W orking
W orking
by min-jolicoeur
with . Different Groups. Module 3 (f). People who...
In vivo control of microorganisms
In vivo control of microorganisms
by conchita-marotz
Antiviral agents . Viruses have one major charact...
Track B
Track B
by karlyn-bohler
Clinical Science, Treatment and Care. ZIMBABWE ...
Pre-Exposure Prophylaxis (
Pre-Exposure Prophylaxis (
by ellena-manuel
PrEP. ) . Initiative:. Open Label Extension. Robe...
Budget issues driving/affecting treatment choice:
Budget issues driving/affecting treatment choice:
by pamella-moone
Community involvement in the . London ARV tender ...
AN  INVESTIGATION OF THE DETERMINANTS OF ADHERENCE TO HIGHL
AN INVESTIGATION OF THE DETERMINANTS OF ADHERENCE TO HIGHL
by tatiana-dople
Meck Chongo, . Virginia . Russell, . Josée. Lav...
The Bangkok Tenofovir Study
The Bangkok Tenofovir Study
by marina-yarberry
An HIV pre-exposure prophylaxis trial in Thailand...
TENNESSEE T.A.L.K.S.
TENNESSEE T.A.L.K.S.
by test
TEACHING. ACTIVITIES THAT. LEAD TO. KNOWLEDGE AND...
Addressing the intersection of criminalisation, discriminat
Addressing the intersection of criminalisation, discriminat
by jane-oiler
Susan Timberlake. Chief, Human Rights and Law Div...
Yale College Student Investment Group
Yale College Student Investment Group
by lois-ondreau
Gilead Sciences Inc. (GILD). Presented by: . Sudh...
Chapter Eleven
Chapter Eleven
by mitsue-stanley
Communicable Diseases. The Importance of Communic...
Tuberculosis
Tuberculosis
by jane-oiler
Dr Gregg Eloundou. Dr Ricky Jones. What is TB?. T...
Switching people who inject drugs from high dead space to l
Switching people who inject drugs from high dead space to l
by cheryl-pisano
William Zule; Harry Cross. RTI International, Uni...
Biochemical Examples of CHEM321/322 Concepts
Biochemical Examples of CHEM321/322 Concepts
by olivia-moreira
Stereochemistry. Many biomolecules, including pro...
Thank you for viewing this presentation.
Thank you for viewing this presentation.
by ellena-manuel
We would like to remind you that this material is...
Substance use disorders and other addictions – Treatment and intervention principles
Substance use disorders and other addictions – Treatment and intervention principles
by gabriella
NIDA principles of effective treatment. AIDS=acqui...
Switching to  Bictegravir
Switching to Bictegravir
by emery
/. Emtricitabine. /. Tenofovir. . Alafenamide. (...
Harm Reduction as a  Public Health Tool
Harm Reduction as a Public Health Tool
by ceila
Facing Addiction in the New River Valley. May 29, ...
Anti viral Drugs 2 DIDANOSINE
Anti viral Drugs 2 DIDANOSINE
by sadie
IDOXURIDINE trifloride. GANCICLOVIR . . ...